If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNKS.L Regulatory News (CNKS)

  • There is currently no data for CNKS

Directorate Changes

5 Jul 2017 07:00

RNS Number : 1247K
Cenkos Securities PLC
05 July 2017
 



5 July 2017

 

Cenkos Securities plc

("Cenkos" or the "Company")

 

Directorate Changes

As reported on 12 May 2017, Jim Durkin, the Company's Chief Executive Officer had informed the Company of his intention to retire from the Company. The Company has since undertaken a search for a successor to Jim Durkin.

Following the completion of this search, Cenkos is pleased to announce that, subject to FCA approval, Anthony Hotson is to be appointed as an Executive Director and to the position of Chief Executive Officer with effect from 1 August 2017. Anthony Hotson has been a Non-Executive Director of the Company since May 2012.

Jim Durkin will resign from the Board and from the position of Chief Executive Officer on 1 August 2017 and will leave the Company on 31 December 2017.

Anthony has extensive experience in financial services having previously worked for the Bank of England, McKinsey & Company and S.G. Warburg. He started his career in the Economics Division of the Bank of England, subsequently moving to the Governors' Office and Money Markets Division. In 1986, he was seconded to the newly-formed Building Societies Commission as Assistant Commissioner. Thereafter, he was employed by McKinsey & Company before joining the corporate finance division of S.G. Warburg. He was a Director of S.G. Warburg & Co. Ltd. from 1992 to 1995 and subsequently Managing Director and Head of the Financial Institutions Group, SBC Warburg (subsequently UBS) until 1998. Following this he served as Non-Executive director in the insurance, fund management and banking sectors, including as a Non-Executive Director of Henderson Group plc where he was a member of the group board and Chairman of its subsidiary companies, London Life and Towry Law. Anthony is Deputy Director of the Centre for Financial History and a senior member of Darwin College, Cambridge.

Gerry Aherne, Chairman said:

"The Board would like to thank Jim for all his hard work and the significant contribution that he has made to the development of the business and he will leave with our best wishes."

"I have every confidence in Anthony in leading the Company going forward as the Company's new Chief Executive Officer. Anthony is exceptionally well placed to undertake the role and his wealth of experience will be a valuable asset for the Company in his new executive role. Having been a director of the Company since May 2012, Anthony has previously been involved in reviewing the firm's structure, governance and processes, including the impact that changing regulations may have, and he has been actively involved with the management of the Company in this respect. "

 

Enquiries:

 

Jim Durkin +44 20 7397 8900

Chief Executive Officer

Cenkos Securities plc

 

Dr Azhic Basirov / David Jones / Ben Jeynes +44 20 7131 4000

Nominated Adviser

Smith & Williamson Corporate Finance Limited

 

David Rydell / Duncan Mayall +44 20 3772 2496

Bell Pottinger

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABLGDRUSGBGRS
Date   Source Headline
15th Apr 20199:48 amRNSForm 8.5 (EPT/NON-RI)
12th Apr 201911:05 amRNSForm 8.5 (EPT/NON-RI)
11th Apr 20199:57 amRNSForm 8.5 (EPT/NON-RI)
10th Apr 201912:36 pmRNSPDMR Shareholding
10th Apr 201912:35 pmRNSEBT Share Transfer
8th Apr 20195:05 pmRNSEBT Share Purchase
5th Apr 20192:30 pmRNSEBT Share Purchase
5th Apr 20191:57 pmRNSAnnual Report and Annual General Meeting Notice
2nd Apr 201912:27 pmRNSEBT Share Purchase
1st Apr 201912:08 pmRNSEBT Share Purchase
1st Apr 201910:16 amRNSDirectorate Changes
26th Mar 201912:33 pmRNSDirector/PDMR Shareholding
26th Mar 20197:00 amRNSAnnual Results for the year ended 31 December 2018
13th Mar 201910:54 amRNSEBT Share Purchase
11th Mar 20197:00 amRNSDirectorate Change
19th Feb 20191:05 pmRNSEBT Share Purchase
7th Feb 201910:19 amRNSEBT Share Purchase
29th Jan 201910:08 amRNSEBT Share Purchase
28th Jan 201911:11 amRNSEBT Share Purchase
25th Jan 201910:44 amRNSEBT Share Purchase
23rd Jan 20194:14 pmRNSEBT Share Purchase Plan
19th Dec 20183:50 pmRNSTrading Update
12th Dec 20183:56 pmRNSEBT Share Purchase
12th Dec 20187:45 amRNSAcquisition of Business
12th Dec 20187:00 amRNSDirectorate Changes
28th Nov 20184:09 pmRNSEBT Share Purchase
28th Nov 201810:00 amRNSPDMR Shareholding
7th Nov 201810:35 amRNSEBT Share Purchase
6th Nov 20185:10 pmRNSAward of shares under SIP and Directors' Dealings
6th Nov 20181:33 pmRNSEBT Share Purchase
5th Nov 20187:00 amRNSBoard Changes
31st Oct 20184:29 pmRNSBoard Change
16th Oct 20185:14 pmRNSBlock listing Interim Review
9th Oct 20187:00 amRNSBoard Change
3rd Oct 201810:02 amRNSEBT Share Purchase
18th Sep 20187:00 amRNSInterim Results for six months ended 30 June 2018
10th Sep 201812:00 pmRNSEBT Share Purchase
7th Sep 201810:19 amRNSEBT Share Purchase
16th Aug 201812:19 pmRNSEBT Share Purchase
6th Aug 201812:02 pmRNSEBT Share Purchase
1st Aug 20187:00 amRNSAcquisition of business
24th Jul 201811:06 amRNSSecond Price Monitoring Extn
24th Jul 201811:00 amRNSPrice Monitoring Extension
24th Jul 20187:00 amRNSTrading Update
23rd Jul 20185:33 pmRNSEBT Share Purchase
20th Jul 20187:00 amRNSChange of Adviser
3rd Jul 20189:02 amRNSForm 8.5 (EPT/NON-RI)
2nd Jul 20189:47 amRNSForm 8.5 (EPT/NON-RI)
29th Jun 201810:31 amRNSForm 8.5 (EPT/NON-RI)
25th Jun 201811:50 amRNSEBT Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.